Clinical Trial Update: Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial) [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update describing the addition of dexmedetomidine to ropivacaine-induced supraclavicular block in the ADRIB trial; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Radius Fracture
• Distal Ulna Fracture
• Forearm Fracture
• Hand Injury
• Wrist Injury

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Guangzhou First People's Hospital | Conditions: Radius Fractures, Ulna Fractures | Phase 4 | Status: COMPLETED